CoQ10 na ƙaruwa a jini, amma ba ya kai ga mitochondria
Wani sabon gwajin kan mutane ya duba tasirin karfafa ƙara CoQ10 a kan tsawon rai. A cikin manya 40 masu lafiya, masu shekaru a ƙasa da 80, shan 400 mg na CoQ10 a kowace rana na tsawon makonni 12 ya haɓaka matakin CoQ10 a jini, amma ba a samu wani canji a matakin CoQ10 a tsoka, a aikin mitochondria, ko a sarrafa sukari da VO₂max ba. Gwajin ya kasance ƙarami, gajere, kuma an yi shi ne a kan manya masu ƙarfi, yayin da babban marubuci ke bayar da shawara ga kamfanin Pharma Nord. Ga abin da sakamakon ke nuni da shi, abin da ba a iya faɗi ba, da kuma tambayoyin da har yanzu ke buƙatar amsa daga likita.
Me Zai Sake Faruwa Idan Kayan Ƙari Biyu Masu Araha Suka Rage Hadarin Mutuwar Zuciya da Rabi?
Kayan ƙari biyu—CoQ10 da selenium—sun rage adadin mutuwar zuciya daga kashi 12.6% zuwa 5.9% a cikin manyan mutane a Sweden. Alamu kamar NT‑proBNP da sakamakon echo‑cardiography ma sun inganta. Sai dai gwajin ya ƙunshi mutane 443 ne kawai, daga yankin da ke da ƙarancin selenium, kuma ba a san wane sinadari ne ya haifar da sakamakon ba. Wannan shi ne abin da binciken KiSel‑10 ya bayyana, waɗanda za su iya amfana, da ƙuntatawar amincin da ya kamata a sani kafin a yi amfani da shi.